Contrast Media Use in the Operating Room

被引:10
作者
Bickham, Peggy [1 ,2 ]
Golembiewski, Julie
机构
[1] Univ Illinois, Med Ctr, Hosp Pharm Serv, Chicago, IL 60612 USA
[2] Univ Illinois, Coll Pharm, Dept Pharm Practice, Chicago, IL USA
关键词
contrast media; postanesthesia care; surgery; NEPHROGENIC SYSTEMIC FIBROSIS; INDUCED NEPHROPATHY; RENAL-INSUFFICIENCY; RISK-FACTORS; GADOLINIUM; ANGIOGRAPHY; IODIXANOL; TRIAL;
D O I
10.1016/j.jopan.2010.01.013
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Iodinated contrast media is frequently used in the OR, but often is not well understood by health care providers who are administering it. Although used for diagnosis rather than treatment, contrast media is classified as a drug by the FDA, and has indications, contraindications, adverse effects, drug interactions, disease interactions, and laboratory interference issues related to its use. Iodinated contrast media is classified according to osmolarity and ionicity, and these characteristics contribute to potential for adverse effects and choice of agent. Financial and safety concerns are factors to he considered when selecting an appropriate agent. Adverse effects can range from mild and self-limited to severe and life threatening; potentially the most serious of these are anaphylactoid reactions and contrast-induced acute renal failure. Knowledge of risk factors and preventive strategies is vital, as are issues related to substitution of gadolinium-based contrast; an off-label use. It is important for the perianesthesia nurse to become familiar with these commonly used imaging medications.
引用
收藏
页码:94 / 100
页数:7
相关论文
共 38 条
[1]  
American College of Radiology
[2]  
ACR Committee on Drugs and Contrast Media, 2008, MAN CONTR MED VERS 6
[3]   ACC/AHA 2007 guide lines for the management of patients with unstable Angina/Non-ST-Elevation myocardial infraction - Executive summary [J].
Anderson, Jeffrey L. ;
Adams, Cynthia D. ;
Antman, Elliott M. ;
Bridges, Charles R. ;
Califf, Robert M. ;
Casey, Donald E., Jr. ;
Chavey, William E., II ;
Fesmire, Francis M. ;
Hochman, Judith S. ;
Levin, Thomas N. ;
Lincoff, A. Michael ;
Peterson, Eric D. ;
Theroux, Pierre ;
Wenger, Nanette Kass ;
Wright, R. Scott ;
Smith, Sidney C., Jr. ;
Jacobs, Alice K. ;
Adams, Cynthia D. ;
Riegel, Barbara .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 50 (07) :652-726
[4]  
[Anonymous], K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification
[5]   Preventing nephropathy induced by contrast medium [J].
Barrett, BJ ;
Parfrey, PS .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (04) :379-386
[6]   Contrast-induced nephropathy in patients with chronic kidney disease undergoing computed tomography - A double-blind comparison of iodixanol and iopamidol [J].
Barrett, Brendan J. ;
Katzberg, Richard W. ;
Thomsen, Henrik S. ;
Chen, Nan ;
Sahani, Dushyant ;
Soulez, Gilles ;
Heiken, Jay P. ;
Lepanto, Luigi ;
Ni, Zhou-Hui ;
Nelson, Rendon .
INVESTIGATIVE RADIOLOGY, 2006, 41 (11) :815-821
[7]   An overview of the clinical pharmacokinetics of x-ray contrast media [J].
Bourin, M ;
Jolliet, P ;
Ballereau, F .
CLINICAL PHARMACOKINETICS, 1997, 32 (03) :180-193
[8]   Gadolinium-based contrast agents and nephrotoxicity in patients undergoing coronary artery procedures [J].
Briguori, C ;
Colombo, A ;
Airoldi, F ;
Melzi, G ;
Michev, I ;
Carlino, M ;
Montorfano, M ;
Chieffo, A ;
Bellanca, R ;
Ricciardelli, B .
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2006, 67 (02) :175-180
[9]   Renal insufficiency following contrast media administration trial (REMEDIAL) - A randomized comparison of 3 preventive strategies [J].
Briguori, Carlo ;
Airoldi, Flavio ;
D'Andrea, Davide ;
Bonizzoni, Erminio ;
Morici, Nuccia ;
Focaccio, Amelia ;
Michev, Iassen ;
Montorfano, Matteo ;
Carlino, Mauro ;
Cosgrave, John ;
Ricciardelli, Bruno ;
Colombo, Antonio .
CIRCULATION, 2007, 115 (10) :1211-1217
[10]   Contrast media hypersensitivity - scope of the problem [J].
Brockow, K .
TOXICOLOGY, 2005, 209 (02) :189-192